“Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 Weeks: Subgroup Analyses from the Effisayil 2 Trial ”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s245. Accessed July 3, 2025. https://skin.dermsquared.com/skin/article/view/2431.